Description

STERIS: Is Its Aggressive EMEA Push the Hidden Catalyst Investors Are Overlooking?

STERIS plc reported its third-quarter results for fiscal year 2026, highlighting both growth and challenges. The company’s revenue increased by 9% year-over-year, with constant currency organic revenue growth at 8%. This growth was fueled by volume increases and a favorable pricing environment that contributed 200 basis points to revenue growth. Despite this positive top-line performance, there was a decline of 70 basis points in gross margin, reducing it to 43.9%. The company attributes this decline to the adverse impacts of increased tariffs and inflation, which outweighed the benefits from positive pricing and productivity enhancements. Operating expenses were controlled effectively, which helped to mitigate some of the pressure on profitability. However, the EBIT margin still saw a decline of 40 basis points to 22.9% compared to the same period last year. The adjusted effective tax rate decreased slightly to 24.2%, benefiting from a favorable geographic mix.